- Report
- October 2024
- 195 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- August 2024
- 139 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2024
- 180 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 132 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
The Luteinizing Hormone Test (LH Test) is a type of in vitro diagnostics (IVD) used to measure the amount of luteinizing hormone (LH) in a patient's blood or urine. LH is a hormone produced by the pituitary gland that helps regulate the menstrual cycle and fertility in women. The LH Test is used to diagnose infertility, polycystic ovary syndrome, and other reproductive disorders. It is also used to monitor the effectiveness of fertility treatments.
The LH Test market is a subset of the larger IVD market, which is estimated to be worth billions of dollars. The LH Test market is expected to grow at a steady rate due to the increasing prevalence of infertility and other reproductive disorders.
Some of the major companies in the LH Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more